Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Upfront immunization with autologous recombinant idiotype Fab fragment without prior cytoreduction in indolent B-cell lymphoma

Marcelo A. Navarrete, Kristina Heining-Mikesch, Frank Schüler, Cristina Bertinetti-Lapatki, Gabriele Ihorst, Andrea Keppler-Hafkemeyer, Gottfried Dölken, Hendrik Veelken

Blood (2011) 117 (5): 1483–1491.

https://doi.org/10.1182/blood-2010-06-292342

Published: 2011

Includes: Supplemental data

Journal Articles

Complete Clinical and Molecular Remissions Due to Very Effective GVL Reactions after Allogeneic Blood Stem Cell Transplantation for Mantle Cell Lymphoma in First or Second Remission.

Frank Schüler, MD, William Krüger, MD, Sandra Dölken, Herbert G. Sayer, MD, Dietger W. Niederwieser, MD, Gottfried Dolken, MD

Blood (2007) 110 (11): 2187.

https://doi.org/10.1182/blood.V110.11.2187.2187

Published: 2007

Journal Articles

Clinical Relapses in Follicular Lymphoma Patients Are Preceded by a ≥ 2log Increase of Circulating Lymphoma Cells.

Frank Schüler, Carsten Hirt, Gottfried Dolken

Blood (2007) 110 (11): 4131.

https://doi.org/10.1182/blood.V110.11.4131.4131

Published: 2007

Journal Articles

Prognostic Significance of Quantitative t(14;18) PCR Monitoring in Advanced Stage Follicular Lymphoma Patients.

Carsten Hirt, MD, Frank Schueler, MD, Thomas Kiefer, MD, Antje Haas, MD, Dietger Niederwieser, MD, Sabine Neser, MD, Michael Assmann, MD, Klaus Dachselt, MD, Malte Leithaeuser, MD, Charles S. Rabkin, MD, Michael Herold, MD, Gottfried Dolken, MD

Blood (2006) 108 (11): 2757.

https://doi.org/10.1182/blood.V108.11.2757.2757

Published: 2006

Journal Articles

Kinetics of Immune Responses and Tumor Burden in Patients with Indolent B Cell Lymphomas Receiving Recombinant Idiotype Vaccination as the Sole Treatment.

Cristina Bertinetti, PhD, Frank Schueler, MD, Kristina Heining-Mikesch, MD, Katja Zirlik, MD, Tina Tomann, MD, Brigitte Franke, MD, Gottfried Dolken, MD, Hendrik Veelken, MD

Blood (2006) 108 (11): 2726.

https://doi.org/10.1182/blood.V108.11.2726.2726

Published: 2006

Journal Articles

No Evidence for t(14;18)-Positive Cells in Newborns and Young Children until the Age of 10 Followed by a Linear Increase of the Prevalence in Healthy Individuals until the Age of 50 Years.

Frank Schüler, Lars Dölken, Sandra Dölken, Carsten Hirt, Gerhard Fusch, Britta Bockholdt, Gerd Lorenz, Christoph Fusch, Gottfried Dolken

Blood (2006) 108 (11): 4281.

https://doi.org/10.1182/blood.V108.11.4281.4281

Published: 2006

Journal Articles

Favorable Molecular Responses to Imatinib in CML Patients in Early Chronic Phase in Comparison to Late Chronic Phase Patients after Treatment with Hydroxyurea and Interferon.

Frank Schüler, Malte Leithäuser, Thomas Kiefer, Saskia Richter, Gottfried Dolken

Blood (2006) 108 (11): 4794.

https://doi.org/10.1182/blood.V108.11.4794.4794

Published: 2006

Journal Articles

Molecular Monitoring of Residual Disease in Patients with Mantle Cell Lymphoma and CLL after Allogeneic Bone Marrow Transplantation Post Reduced Intensity Conditioning.

Frank Schüler, MD, Carsten Hirt, MD, Thomas Kiefer, MD, Gottfried Dolken, MD

Blood (2005) 106 (11): 5398.

https://doi.org/10.1182/blood.V106.11.5398.5398

Published: 2005

Journal Articles

Multiplex Quantitative Real-Time PCR for the Detection of t(14;18) Translocations with Breakpoints within 5 Different Regions of the BCL-2 Gene: MBR, 3′MBR, mcr, 5′mcr, icr.

Frank Schüler, MD, Sandra C. Dölken, Carsten Hirt, MD, Gottfried Dolken, MD

Blood (2005) 106 (11): 2826.

https://doi.org/10.1182/blood.V106.11.2826.2826

Published: 2005

Journal Articles

Primary CNS Lymphoma Treated with HD-Methotrexate, HD-Busulfan/Thiotepa, Autologous Stem Cell Transplantation and Response-Adapted Whole-Brain Radiotherapy: Results of the Multicenter OSHO-53 Phase II - Study.

Michael Montemurro, MD, Thomas Kiefer, MD, Frank Schüler, MD, Haifa-Katrin Al Ali, MD, Hans-Heinrich Wolf, MD, Regina Herbst, MD, Antje Haas, MD, Kirsten Helke, MD, Anja Theilig, MD, Christian Lotze, MD, Carsten Hirt, MD, Dietger Niederwieser, MD, Matthias Schwenke, MD, William Krüger, MD, Gottfried Dolken, MD

Blood (2005) 106 (11): 3342.

https://doi.org/10.1182/blood.V106.11.3342.3342

Published: 2005

NARROW

Upfront immunization with autologous recombinant idiotype Fab fragment without prior cytoreduction in indolent B-cell lymphoma

Complete Clinical and Molecular Remissions Due to Very Effective GVL Reactions after Allogeneic Blood Stem Cell Transplantation for Mantle Cell Lymphoma in First or Second Remission.

Clinical Relapses in Follicular Lymphoma Patients Are Preceded by a ≥ 2log Increase of Circulating Lymphoma Cells.

Prognostic Significance of Quantitative t(14;18) PCR Monitoring in Advanced Stage Follicular Lymphoma Patients.

Kinetics of Immune Responses and Tumor Burden in Patients with Indolent B Cell Lymphomas Receiving Recombinant Idiotype Vaccination as the Sole Treatment.

No Evidence for t(14;18)-Positive Cells in Newborns and Young Children until the Age of 10 Followed by a Linear Increase of the Prevalence in Healthy Individuals until the Age of 50 Years.

Favorable Molecular Responses to Imatinib in CML Patients in Early Chronic Phase in Comparison to Late Chronic Phase Patients after Treatment with Hydroxyurea and Interferon.

Molecular Monitoring of Residual Disease in Patients with Mantle Cell Lymphoma and CLL after Allogeneic Bone Marrow Transplantation Post Reduced Intensity Conditioning.

Multiplex Quantitative Real-Time PCR for the Detection of t(14;18) Translocations with Breakpoints within 5 Different Regions of the BCL-2 Gene: MBR, 3′MBR, mcr, 5′mcr, icr.

Primary CNS Lymphoma Treated with HD-Methotrexate, HD-Busulfan/Thiotepa, Autologous Stem Cell Transplantation and Response-Adapted Whole-Brain Radiotherapy: Results of the Multicenter OSHO-53 Phase II - Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only